Eddie Pharmaceuticals: Intends to issue stocks to raise funds not exceeding 1.277 billion yuan.

Eddie Pharmaceutical announced that it plans to issue A shares to a maximum of 35 specific investors, including the controlling shareholder Fu and Liang, raising a total of no more than 1.277 billion yuan. The funds raised, after deducting issuance expenses, will be used for the global clinical development project of a new type of HIV integrase inhibitor, the acquisition of 22.2324% equity of Nanda Pharmaceutical from minority shareholders, and for supplementary working capital. The number of shares to be issued this time will not exceed 126 million shares, and the final issue price will be determined based on the bidding results.